BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35385593)

  • 1. Structure-Based Evolution of G Protein-Biased μ-Opioid Receptor Agonists.
    Wang H; Hetzer F; Huang W; Qu Q; Meyerowitz J; Kaindl J; Hübner H; Skiniotis G; Kobilka BK; Gmeiner P
    Angew Chem Int Ed Engl; 2022 Jun; 61(26):e202200269. PubMed ID: 35385593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Evaluation of Novel Biased μ-Opioid-Receptor (μOR) Agonists.
    Ma M; Sun J; Li M; Yu Z; Cheng J; Zhong B; Shi W
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30641969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and Structural Explorations of G-Protein Biased μ-Opioid Receptor Agonists.
    Li X; Guo Y; Li J; Yu Z; Cheng J; Ren F; Jia H; Zhang Y; Cui S; Zhang T; Shi W
    ChemMedChem; 2022 Dec; 17(24):e202200416. PubMed ID: 36210341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular recognition of morphine and fentanyl by the human μ-opioid receptor.
    Zhuang Y; Wang Y; He B; He X; Zhou XE; Guo S; Rao Q; Yang J; Liu J; Zhou Q; Wang X; Liu M; Liu W; Jiang X; Yang D; Jiang H; Shen J; Melcher K; Chen H; Jiang Y; Cheng X; Wang MW; Xie X; Xu HE
    Cell; 2022 Nov; 185(23):4361-4375.e19. PubMed ID: 36368306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of β-arrestin recruitment by the μ-opioid G protein-coupled receptor.
    Mafi A; Kim SK; Goddard WA
    Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16346-16355. PubMed ID: 32601232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of fentanyl mediated β-arrestin biased signaling.
    de Waal PW; Shi J; You E; Wang X; Melcher K; Jiang Y; Xu HE; Dickson BM
    PLoS Comput Biol; 2020 Apr; 16(4):e1007394. PubMed ID: 32275713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects.
    French AR; van Rijn RM
    Pharmacol Res; 2022 Mar; 177():106091. PubMed ID: 35101565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing Allosteric Regulation Mechanism of W7.35 on Agonist-Induced Activity for μOR by Mutation Simulation.
    Zhang F; Chen X; Chen J; Xu Y; Li S; Guo Y; Pu X
    J Chem Inf Model; 2022 Nov; 62(21):5120-5135. PubMed ID: 34779608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based discovery of opioid analgesics with reduced side effects.
    Manglik A; Lin H; Aryal DK; McCorvy JD; Dengler D; Corder G; Levit A; Kling RC; Bernat V; Hübner H; Huang XP; Sassano MF; Giguère PM; Löber S; Da Duan ; Scherrer G; Kobilka BK; Gmeiner P; Roth BL; Shoichet BK
    Nature; 2016 Sep; 537(7619):185-190. PubMed ID: 27533032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Intracellular Signaling Activities of κ-Opioid Receptor Agonists, Nalfurafine Analogs; Focusing on the Selectivity of G-Protein- and β-Arrestin-Mediated Pathways.
    Yamaguchi M; Miyano K; Hirayama S; Karasawa Y; Ohshima K; Uezono E; Komatsu A; Nonaka M; Fujii H; Yamaguchi K; Iseki M; Hayashida M; Uezono Y
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular insights into the allosteric coupling mechanism between an agonist and two different transducers for μ-opioid receptors.
    Zhang F; Yuan Y; Chen Y; Chen J; Guo Y; Pu X
    Phys Chem Chem Phys; 2022 Mar; 24(9):5282-5293. PubMed ID: 35170592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular insights into the biased signaling mechanism of the μ-opioid receptor.
    Cong X; Maurel D; Déméné H; Vasiliauskaité-Brooks I; Hagelberger J; Peysson F; Saint-Paul J; Golebiowski J; Granier S; Sounier R
    Mol Cell; 2021 Oct; 81(20):4165-4175.e6. PubMed ID: 34433090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carfentanil is a β-arrestin-biased agonist at the μ opioid receptor.
    Ramos-Gonzalez N; Groom S; Sutcliffe KJ; Bancroft S; Bailey CP; Sessions RB; Henderson G; Kelly E
    Br J Pharmacol; 2023 Sep; 180(18):2341-2360. PubMed ID: 37005796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling diversity of mu- and delta- opioid receptor ligands: Re-evaluating the benefits of β-arrestin/G protein signaling bias.
    Pineyro G; Nagi K
    Cell Signal; 2021 Apr; 80():109906. PubMed ID: 33383156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into distinct signaling profiles of the µOR activated by diverse agonists.
    Qu Q; Huang W; Aydin D; Paggi JM; Seven AB; Wang H; Chakraborty S; Che T; DiBerto JF; Robertson MJ; Inoue A; Suomivuori CM; Roth BL; Majumdar S; Dror RO; Kobilka BK; Skiniotis G
    Nat Chem Biol; 2023 Apr; 19(4):423-430. PubMed ID: 36411392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Characterization of µ-Opioid Receptor Agonists with Biased G Protein or β-Arrestin Signaling, and Computational Study of Conformational Changes during Receptor Activation.
    Piekielna-Ciesielska J; Artali R; Azzam AAH; Lambert DG; Kluczyk A; Gentilucci L; Janecka A
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33375124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform.
    Vasudevan L; Vandeputte M; Deventer M; Wouters E; Cannaert A; Stove CP
    Biochem Pharmacol; 2020 Jul; 177():113910. PubMed ID: 32179045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noribogaine is a G-protein biased κ-opioid receptor agonist.
    Maillet EL; Milon N; Heghinian MD; Fishback J; Schürer SC; Garamszegi N; Mash DC
    Neuropharmacology; 2015 Dec; 99():675-88. PubMed ID: 26302653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of pyrazole-1-carboxamide derivatives as novel Gi-biased μ-opioid receptor agonists.
    Jung JH; Jang IH; Kim YO; Kim S; Yoon MH; Kim YC
    Drug Dev Res; 2022 Nov; 83(7):1600-1612. PubMed ID: 36124859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness for the combination of G-protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive tolerance.
    Mori T; Kuzumaki N; Arima T; Narita M; Tateishi R; Kondo T; Hamada Y; Kuwata H; Kawata M; Yamazaki M; Sugita K; Matsuzawa A; Baba K; Yamauchi T; Higashiyama K; Nonaka M; Miyano K; Uezono Y; Narita M
    Mol Pain; 2017; 13():1744806917740030. PubMed ID: 29056067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.